Corticosteroids and rehabilitation in COVID-19 survivors
J Formos Med Assoc
.
2021 May;120(5):1284-1285.
doi: 10.1016/j.jfma.2020.12.005.
Epub 2020 Dec 9.
Authors
Amos Lal
1
,
Ajay Kumar Mishra
2
,
Kevin John
3
,
Jamal Akhtar
4
Affiliations
1
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: Lal.Amos@mayo.edu.
2
Department of Medicine, Saint Vincent Hospital, Worcester, MA, USA. Electronic address: ajaybalasore@gmail.com.
3
Department of Medicine, Bangalore Baptist Hospital, Tiruvalla, Kerala, India. Electronic address: kevinjohn619@gmail.com.
4
Department of Sleep Medicine, Montefiore Medical Center, Bronx, New York, NY, USA. Electronic address: drfarrukhjamal79@gmail.com.
PMID:
33341350
PMCID:
PMC7833073
DOI:
10.1016/j.jfma.2020.12.005
No abstract available
Publication types
Letter
Comment
MeSH terms
Adrenal Cortex Hormones
COVID-19*
Consensus
Humans
SARS-CoV-2
Survivors
Taiwan
Substances
Adrenal Cortex Hormones